P717: BOSUTINIB IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA: GASTROINTESTINAL, LIVER, EFFUSION AND RENAL SAFETY CHARACTERIZATION IN THE BFORE TRIAL
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000845752.32594.93 |
| _version_ | 1797281763512287232 |
|---|---|
| author | J. E. Cortes D. Milojkovic C. Gambacorti-Passerini V. García-Gutiérrez M. J. Mauro E. Leip S. Purcell A. Viqueira T. H. Brümmendorf |
| author_facet | J. E. Cortes D. Milojkovic C. Gambacorti-Passerini V. García-Gutiérrez M. J. Mauro E. Leip S. Purcell A. Viqueira T. H. Brümmendorf |
| author_sort | J. E. Cortes |
| collection | DOAJ |
| first_indexed | 2024-03-07T17:02:08Z |
| format | Article |
| id | doaj.art-9dffe7629fb74c10bb44ae76595b78c5 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T17:02:08Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-9dffe7629fb74c10bb44ae76595b78c52024-03-03T03:19:10ZengWileyHemaSphere2572-92412022-06-01661261310.1097/01.HS9.0000845752.32594.93202206003-00612P717: BOSUTINIB IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA: GASTROINTESTINAL, LIVER, EFFUSION AND RENAL SAFETY CHARACTERIZATION IN THE BFORE TRIALJ. E. Cortes0D. Milojkovic1C. Gambacorti-Passerini2V. García-Gutiérrez3M. J. Mauro4E. Leip5S. Purcell6A. Viqueira7T. H. Brümmendorf81 Georgia Cancer Center, Augusta, United States of America2 Hammersmith Hospital, London, United Kingdom3 University of Milano-Bicocca, Monza, Italy4 Universitario Ramón y Cajal, Ramón y Cajal Health Research Institute, Madrid, Spain5 Memorial Sloan Kettering Cancer Center, New York6 Pfizer Inc, Cambridge, United States of America7 Pfizer Ltd, London, United Kingdom8 Pfizer SLU, Madrid, Spain9 Universitätsklinikum RWTH Aachen, Aachen, Germanyhttp://journals.lww.com/10.1097/01.HS9.0000845752.32594.93 |
| spellingShingle | J. E. Cortes D. Milojkovic C. Gambacorti-Passerini V. García-Gutiérrez M. J. Mauro E. Leip S. Purcell A. Viqueira T. H. Brümmendorf P717: BOSUTINIB IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA: GASTROINTESTINAL, LIVER, EFFUSION AND RENAL SAFETY CHARACTERIZATION IN THE BFORE TRIAL HemaSphere |
| title | P717: BOSUTINIB IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA: GASTROINTESTINAL, LIVER, EFFUSION AND RENAL SAFETY CHARACTERIZATION IN THE BFORE TRIAL |
| title_full | P717: BOSUTINIB IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA: GASTROINTESTINAL, LIVER, EFFUSION AND RENAL SAFETY CHARACTERIZATION IN THE BFORE TRIAL |
| title_fullStr | P717: BOSUTINIB IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA: GASTROINTESTINAL, LIVER, EFFUSION AND RENAL SAFETY CHARACTERIZATION IN THE BFORE TRIAL |
| title_full_unstemmed | P717: BOSUTINIB IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA: GASTROINTESTINAL, LIVER, EFFUSION AND RENAL SAFETY CHARACTERIZATION IN THE BFORE TRIAL |
| title_short | P717: BOSUTINIB IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA: GASTROINTESTINAL, LIVER, EFFUSION AND RENAL SAFETY CHARACTERIZATION IN THE BFORE TRIAL |
| title_sort | p717 bosutinib in newly diagnosed chronic myeloid leukemia gastrointestinal liver effusion and renal safety characterization in the bfore trial |
| url | http://journals.lww.com/10.1097/01.HS9.0000845752.32594.93 |
| work_keys_str_mv | AT jecortes p717bosutinibinnewlydiagnosedchronicmyeloidleukemiagastrointestinallivereffusionandrenalsafetycharacterizationinthebforetrial AT dmilojkovic p717bosutinibinnewlydiagnosedchronicmyeloidleukemiagastrointestinallivereffusionandrenalsafetycharacterizationinthebforetrial AT cgambacortipasserini p717bosutinibinnewlydiagnosedchronicmyeloidleukemiagastrointestinallivereffusionandrenalsafetycharacterizationinthebforetrial AT vgarciagutierrez p717bosutinibinnewlydiagnosedchronicmyeloidleukemiagastrointestinallivereffusionandrenalsafetycharacterizationinthebforetrial AT mjmauro p717bosutinibinnewlydiagnosedchronicmyeloidleukemiagastrointestinallivereffusionandrenalsafetycharacterizationinthebforetrial AT eleip p717bosutinibinnewlydiagnosedchronicmyeloidleukemiagastrointestinallivereffusionandrenalsafetycharacterizationinthebforetrial AT spurcell p717bosutinibinnewlydiagnosedchronicmyeloidleukemiagastrointestinallivereffusionandrenalsafetycharacterizationinthebforetrial AT aviqueira p717bosutinibinnewlydiagnosedchronicmyeloidleukemiagastrointestinallivereffusionandrenalsafetycharacterizationinthebforetrial AT thbrummendorf p717bosutinibinnewlydiagnosedchronicmyeloidleukemiagastrointestinallivereffusionandrenalsafetycharacterizationinthebforetrial |